Clinical trials
Active, not recruiting Wet Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Adverum Biotechnologies, Inc. | 2 |
| 4D Molecular Therapeutics | 1 |
| Elisigen, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Outlook Therapeutics, Inc. | 1 |
| St. Olavs Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wet Macular Degeneration | 9 |
| Macular Degeneration | 8 |
| Choroidal Neovascularization | 5 |
| Eye Diseases | 5 |
| Retinal Degeneration | 4 |
| Retinal Diseases | 4 |
| Blindness | 2 |
| Geographic Atrophy | 1 |
| Retinal Vein Occlusion | 1 |
| Vision Disorders | 1 |
Trials
Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.